PUBLICATION

Zebrafish developmental toxicity assay: A fishy solution to reproductive toxicity screening, or just a red herring?

Authors
Van den Bulck, K., Hill, A., Mesens, N., Diekman, H., De Schaepdrijver, L., and Lammens, L.
ID
ZDB-PUB-110629-35
Date
2011
Source
Reproductive toxicology (Elmsford, N.Y.)   32(2): 213-9 (Journal)
Registered Authors
Diekmann, Heike, Hill, Adrian
Keywords
zebrafish, developmental toxicity, screen, alternative, embryo, predictive, exposure
MeSH Terms
  • Animals
  • Body Burden
  • Congenital Abnormalities/etiology
  • Dose-Response Relationship, Drug
  • Embryo, Nonmammalian/abnormalities
  • Embryo, Nonmammalian/drug effects*
  • Embryonic Development/drug effects*
  • Endpoint Determination
  • False Positive Reactions
  • Teratogens/pharmacokinetics
  • Teratogens/toxicity*
  • Toxicity Tests*/methods
  • Toxicity Tests*/standards
  • Toxicity Tests*/statistics & numerical data
  • Zebrafish/abnormalities
  • Zebrafish/embryology*
PubMed
21704152 Full text @ Reprod. Toxicol.
Abstract

The zebrafish embryotoxicity/teratogenicity assay is described as a useful alternative screening model to evaluate the effect of drugs on embryofoetal development.

Fertilized eggs were exposed to different concentrations of 15 compounds with teratogenic (8) and non-teratogenic (7) potential until 96 h post-fertilization when 28 morphological endpoints and the level of compound uptake was assessed.

The majority of drugs testing positive in mammals was also positive in zebrafish (75% sensitivity), while a relative high number of false positives were noted (43% specificity). Compound uptake determination appears useful for clarifying classifications as teratogenic or potential overdose although assay sensitivity could be improved to 71% if the exposure threshold, previously suggested as not, vert, similar50 ng/larvae, is reconsidered.

The zebrafish assay shows some potential, though limited in its current form, as a screening tool for developmental toxicity within Janssen drug development. Further assay refinement with respect to endpoints and body burden threshold is required.

Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping